A61P 5/26
Androgens
A61P5/26 (Androgens) appears on 597 US grants and 915 published applications in this corpus.
Search patents in A61P- Granted patents
- 597
- Published applications
- 915
- Assignees
- 332
- Inventors
- 1,331
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 15 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 6 | 2 |
| 2002 | 11 | 27 |
| 2003 | 16 | 32 |
| 2004 | 14 | 50 |
| 2005 | 14 | 49 |
| 2006 | 11 | 47 |
| 2007 | 22 | 53 |
| 2008 | 29 | 52 |
| 2009 | 26 | 59 |
| 2010 | 45 | 63 |
| 2011 | 36 | 57 |
| 2012 | 30 | 42 |
| 2013 | 42 | 40 |
| 2014 | 37 | 49 |
| 2015 | 35 | 39 |
| 2016 | 30 | 44 |
| 2017 | 26 | 37 |
| 2018 | 20 | 30 |
| 2019 | 18 | 23 |
| 2020 | 23 | 23 |
| 2021 | 12 | 20 |
| 2022 | 10 | 15 |
| 2023 | 12 | 17 |
| 2024 | 8 | 17 |
| 2025 | 13 | 20 |
| 2026 | 11 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of using a needle assisted injection device having reduced trigger force18 Aug 2026US 12,708,710 B2Antares Pharma, Inc.
- Non-surgical prevention of boar taint and aggressive behavior4 Aug 2026US 12,697,342 B2Insigna Inc.
- Fixed dose oral testosterone undecanoate compositions and use thereof28 Jul 2026US 12,691,057 B1
- Proliposomal testosterone undecanoate formulations19 May 2026US 12,629,381 B2
- Stabilized receptor polypeptides and uses thereof19 May 2026US 12,630,608 B2Amgen Inc.
- Androgen receptor antagonists for the treatment of patients with biochemical recurrence of hormone sensitive prostate cancer3 Sep 2026US 2026/0256742 A1
- Fusion protein comprising follicle stimulating hormone and antigen-binding fragment to serum albumin and compositions and uses thereof7 May 2026US 2026/0125443 A1AprilBio Co., Ltd.
- Administration of testosterone compositions16 Apr 2026US 2026/0102409 A1Antares Pharma, Inc.
- Testosterone containing pharmaceutical composition26 Mar 2026US 2026/0083755 A1Neurocrine UK Limited
- Compositions for non-surgical prevention of boar taint and aggressive behavior19 Mar 2026US 2026/0076978 A1Insigna Inc.
Most cited
By later US patents
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Compositions and methods for improved delivery of hydrophobic agents332US 6,451,339 B2Lipocine Inc. · 2002
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001
- Drug delivery compositions for improved stability of steroids135US 5,780,050 ATheratech, Inc. · 1998
- Dermal penetration enhancers and drug delivery systems involving same130US 6,818,226 B2Acrux DDS Pty Ltd · 2004